ISSN 0955-8810; 1473-5849;
4 papers in the library · 37 citations · publishing 1996-2026
Behav Pharmacol July 1, 2026 Razeen J. Akbar, Amy D. Stringer, Sonita Wiah et al.
Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanisms.
Behav Pharmacol December 6, 2024 Daaniyal D. Munir, Ritu A. Shetty, Michael B. Gatch et al. 1 citation
Despite the efforts of the Drug Enforcement Administration to safeguard the public from hazardous analogs of synthetic hallucinogens, these compounds have increasingly been observed in the illicit drug market. Four novel compounds were found to be similar in structure to the previously described 25X-NBOMe synthetic hallucinogens. These four compounds, 25B-NBOH, 25C-NBOH, 25E-NBOH, and 25I-NBOH...
Behav Pharmacol August 1, 2017 Michael B. Gatch, Sean B. Dolan, Michael J. Forster 36 citations
There has been increasing use of novel synthetic hallucinogenic compounds, 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine hydrochloride (25B-NBOMe), 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine hydrochloride (25C-NBOMe), 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine hydrochloride (25I-NBOMe), and N,N-diallyl-5-methoxy tryptamine (5-MeO-DALT),...
Behav Pharmacol March 1, 1996
Tolerance to the discriminative stimulus and reinforcing effects of ketamine.